This clinical cohort trial evaluates the clinical utility of early 18F-fluorodeoxyglucose positron emission tomography for improving outcome estimation compared with standard diagnostic evaluation in patients with newly diagnosed metastatic breast cancer.
JAMA Oncology published a clinical update in Oncology on 16 Apr 2026. The item focuses on FDG-PET for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer. Open the detail page to review the full original feed content.